Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats

Pharmacology

Volumn 76, Issue 2, 2006, Pages 69-75

  Sharma, Sameer ^a   Anjaneyulu, Muragundla ^a   Kulkarni, S K ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Diabetic nephropathy; Lipid peroxidation; Oxidative stress; Resveratrol streptozotocin

Indexed keywords

ANTIOXIDANT; CATALASE; CREATININE; GLUCOSE; GLUTATHIONE; MALONALDEHYDE; PHYTOALEXIN; POLYPHENOL DERIVATIVE; RESVERATROL; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY HOMOGENATE; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POLYURIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION; URINE VOLUME; WEIGHT REDUCTION;

ANIMALS; ANTIOXIDANTS; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; KIDNEY; KIDNEY FUNCTION TESTS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; SUPEROXIDE DISMUTASE; TERPENES;

EID: 31144447091     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089720     Document Type: Article

References (26)

1. Baynes JW: Role of oxidative stress in development of complication in diabetes. Diabetes 1991;40:405-412.
2. Ha H, Kim KH: Role of oxidative stress in the development of diabetic nephropathy. Kidney Int 1995;48(suppl 5):S18-S21.
3. Paolisso G, Amore DA, Galzerano D: Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetes patients. Diabetes Care 1993;16:433-437.
4. Ruiz C, Alegria A, Barbera R, Farre R, Lagarda MJ: Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 1994;59:99-105.
5. Ruiz-Munoz LM, Vidal-Vanacloch F, Lampreabe I: Enalaprilat inhibits hydrogen peroxide production by murine mesangial cells exposed to high glucose concentration. Nephrol Dial Transplant 1997;12:456-464.
6. Ha H, Lee SH, Kim KH: Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor-β and fibronectin, lipid peroxidation induced by high glucose in cultured mesangial cells. J Pharmacol Exp Ther 1997;281:1457-1462.
7. Cooper ME: Interaction of metabolic and homodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001;44:1957-1972.
8. Haworth RS, Avkiran M: Inhibition of protein kinase D by resveratrol. Biochem Pharmacol 2001;62:1647-1651.
9. Holian O, Wahid S, Atten MJ, Attar BM: Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide. Am J Physiol 2002;282:G809-G816.
10. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM: Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β. Endocrinology 2000;141:3657-3667.
11. Indian National Science Academy: Guidelines for Care and Use of Animals in Scientific Research. New Delhi, INSA, 1992.
12. Murali B, Goyal RK: Effect of chronic treatment with losartan on streptozotocin-induced diabetic nephropathy. Clin Exp Hypertens 2001;23:513-520.
13. Schmidt FH: Methoden der Harn- und Blutzuckerbestimmung. II. Handb Dtsch Diabetes Mellitus 1971;2:938.
14. Anjaneyulu M, Ramarao P: Studies on gastrointestinal tract functional changes in diabetic animals. Methods Find Exp Clin Pharmacol 2002;2:71-75.
15. Wills ED: Mechanism of lipid peroxide formation in animal tissues. Biochem J 1996;99:667-676.
16. Ellman GL: Tissue sulfhydryl group. Arch Biochem Biophys 1959;82:70-77.
17. Kono Y: Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 1978;186:189-195.
18. Luck H: Catalase; in Bergmeyer HU (ed): Methods of Enzymatic Analysis. New York, Academic Press, 1971, pp 885-893.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
20. Sugimoto K, Tsuruoko S, Fujimura A: Effect of enalapril on diabetic nephropathy in OLETF rats: The role of an anti-oxidative action in its protective properties. Clin Exp Pharmacol Physiol 2001;28:829-830.
21. Craven PA, Melhem MF, DeRubertis FR: Thromboxane in the pathogenesis of glomerular injury in diabetes. Kidney Int 1992;42:937-946.
22. Burkitt MJ, Duncan J: Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: Evidence for hydroxyl-radical scavenging and a novel glutathione-sparing mechanism of action. Arch Biochem Biophys 2000;381:253-263.
23. Olas B, Wachowicz B: Resveratrol and vitamin C as antioxidants in blood platelets. Thromb Res 2002;106:143-148.
24. Wilmer WA, Dixon CL, Hebert C: Chronic exposure of human mesangial cell to high glucose environments activates p38 MAPK pathway. Kidney Int 2001;60:858-871.
25. Ziyadeh F, Han DC: Involvement of transforming growth factor-β and its receptors in the pathogenesis of diabetic nephropathy. Kidney Int 1997;52(suppl 60):S7-S11.
26. Slater SJ, Seiz JL, Cook AC, Stagliano BA, Buzas CJ: Inhibition of protein kinase C by resveratrol. Biochim Biophys Acta 2003;1637:59-69.